Načítá se...
Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells
The phosphoinositide 3-kinase/Akt pathway activation commonly occurs in various types of human cancer and has an important role in chemoresistance. Combination of traditional chemotherapy drugs and molecular-targeted agents is a promising strategy for cancer therapy, which has shown enhanced cytotox...
Uloženo v:
| Vydáno v: | Biomed Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774399/ https://ncbi.nlm.nih.gov/pubmed/26998277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.594 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|